REYMOND; Jean-Louis

Patent Applications and Registrations

Patent applications and USPTO patent grants for REYMOND; Jean-Louis.The latest application filed is for "information retrieval and/or visualization method".

Company Profile

7.9.12

REYMOND; Jean-Louis - Bulle CH
Reymond; Jean-Louis - Berne N/A CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Information Retrieval And/or Visualization Method App 20220300528 - REYMOND; Jean-Louis ; et al.	2022-09-22
Antimicrobial Tailored Chitosan App 20220193244 - JORDAN; Olivier ; et al.	2022-06-23
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,774,077 - Reymond , et al. Sept	2020-09-15
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular App 20190382397 - REYMOND; Jean-Louis ; et al.	2019-12-19
Selective Aurora A Kinase Inhibitors App 20190352297 - REYMOND; Jean-Louis ; et al.	2019-11-21
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,392,377 - Reymond , et al. A	2019-08-27
Antimicrobial peptide dendrimers Grant 10,336,792 - Darbre , et al.	2019-07-02
Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation Grant 10,300,048 - Reymond , et al.	2019-05-28
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20190119265 - REYMOND; Jean-Louis ; et al.	2019-04-25
Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors Grant 10,155,754 - Reymond , et al. Dec	2018-12-18
Thiazolidinones As Cellular Anandamide Uptake Inhibitors And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20170296515 - REYMOND; Jean-Louis ; et al.	2017-10-19
Thiazolidinone Compounds And Their Use In The Treatment Of Psychiatric Or Neurological Disorders And Inflammation, In Particular Neuroinflammation App 20170197952 - REYMOND; Jean-Louis ; et al.	2017-07-13
Antimicrobial Peptide Dendrimers App 20170137471 - DARBRE; Tamis ; et al.	2017-05-18
Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof Grant 8,741,593 - Reymond , et al. June 3, 2	2014-06-03
Process for generating the idiosyncratic catalytic imprint of a sample, the processing of said imprint and the systems for implementation thereof Grant 7,258,972 - Reymond , et al. August 21, 2	2007-08-21
Method for detecting catalytic activity Grant 7,238,483 - Reymond , et al. July 3, 2	2007-07-03
Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof App 20070099257 - Reymond; Jean-Louis ; et al.	2007-05-03
Method for detecting catalytic activity App 20050014212 - Reymond, Jean-Louis ; et al.	2005-01-20
Process for generating the idiosyncratic catalytic imprint of a sample, the process of said imprint and the systems for implementation thereof App 20050009098 - Reymond, Jean-Louis ; et al.	2005-01-13
Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof App 20030199017 - Reymond, Jean-Louis ; et al.	2003-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.